Erlotinib and dyspnoea Patient Reports February 11, 2012

Erlotinib Side Effects Report #5196227-4
Erlotinib side effect was reported by a Physician from GERMANY on Dec 07, 2006. Female patient, 72 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, dyspnoea, epistaxis, pancreatic carcinoma metastatic, pleural effusion, pneumothorax. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with ASPIRIN, NEXIUM, SIMVAHEXAL, GEMCITABINE, XANEF, UNAT, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5711267-1
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on Mar 31, 2008. Male patient, 40 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest discomfort, cholangitis, dyspnoea, febrile neutropenia, hepatitis , jaundice cholestatic, night sweats. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with CAPECITABINE, GEMCITABINE, PYRIDOXINE, RAMOSETRON HYDROCHLORIDE, NOVOLIN N, METOCLOPRAMIDE, OXYCODONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5736886-8
Erlotinib side effect was reported by a Health Professional from KOREA, REPUBLIC OF on Apr 23, 2008. Male patient, 40 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest discomfort, cholangitis, dyspnoea, febrile neutropenia, hepatitis , lymphocyte count decreased, monocyte count decreased, night sweats, platelet count decreased. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with CAPECITABINE, GEMCITABINE, PYRIDOXINE, RAMOSETRON, NOVOLIN N, METOCLOPRAMIDE, OXYCODONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5766192-7
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on May 19, 2008. Male patient, 40 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea, eastern cooperative oncology group performance status worsened, febrile neutropenia, haematocrit decreased, hepatitis cholestatic, jaundice cholestatic, laboratory test abnormal, lymphocyte count decreased. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with CAPECITABINE, GEMCITABINE, PYRIDOXINE, RAMOSETRON, NOVOLIN N, METOCLOPRAMIDE, OXYCODONE. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5819961-9
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2008. Female patient, 75 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: candidiasis, dyspnoea, lung infection, malignant neoplasm progression, metastases to lung, oxygen saturation decreased, pyrexia. Erlotinib dosage: 150 MG, QD, DAYS 1-28, ORAL. During the same period patient was treated with SORAFENIB, GEMCITABINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4928557-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 08, 2006. Female patient, 65 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal distension, diarrhoea, dyspnoea, pleural effusion, pneumonia , pulmonary embolism . Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5407966-1
Erlotinib side effect was reported by a Physician from UNITED STATES on July 19, 2007. Male patient, 60 years of age, weighting 166.4 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest discomfort, chest pain , dehydration, diarrhoea, dyspnoea, hyperglycaemia, hyperhidrosis, hyponatraemia, hypotension. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5420941-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 03, 2007. Male patient, 60 years of age, weighting 166.4 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, chest pain , dehydration, diarrhoea, dyspnoea, hyperglycaemia, hyperhidrosis, hyponatraemia, hypotension. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5572355-6
Erlotinib side effect was reported by a Physician from ISRAEL on Dec 04, 2007. Male patient, 83 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, dyspnoea, pleural effusion, protein total decreased. Erlotinib dosage: (50 MG, QD), ORAL. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #6093027-8
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Feb 09, 2009. Female patient, 83 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, infection , malaise. Erlotinib dosage: 150 MG, ORAL. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5062558-1
Erlotinib side effect was reported by a Physician from ITALY on July 05, 2006. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, pyrexia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with LASIX, LOSARTAN POSTASSIUM, DIGOXIN, FLECAINIDE ACETATE, BISOPROLOL FUMARATE, RANITIDINE, METHYLPREDNISOLONE, SIMVASTATIN. Patient was hospitalized. Patient died on 06/30/2006.

Erlotinib Side Effects Report #5192756-8
Erlotinib side effect was reported by a Physician from VENEZUELA on Dec 04, 2006. Female patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, dyspnoea, respiratory tract infection. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5710611-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 01, 2008. Female patient, 75 years of age, weighting 151.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain lower, anaemia, diarrhoea, diverticulum, dyspnoea, fatigue, gallbladder disorder, haematocrit decreased, haemoglobin decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, NORVASC, BENAZEPRIL, LEXAPRO, DETROL, CLARINEX, HYDROCHLOROTHIAZIDE, IRON POLYSACCHARIDE. Patient was hospitalized and became disabled. Patient recovered.

Erlotinib Side Effects Report #5402034-7
Erlotinib side effect was reported by a Physician from ITALY on July 12, 2007. Male patient, 73 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bone pain, dyspnoea, non-cardiac chest pain, osteoporotic fracture, thoracic vertebral fracture. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died on 07/25/2006.


Erlotinib Side Effects Report #5927963-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 22, 2008. Female patient, 73 years of age, weighting 123.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion. Erlotinib dosage: 150MG ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5956176-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 04, 2008. Female patient, 73 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5963123-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 20, 2008. Female patient, 73 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, electrocardiogram abnormal, pericardial effusion. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6058145-9
Erlotinib side effect was reported by a Health Professional from KOREA, REPUBLIC OF on Jan 13, 2009. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, interstitial lung disease. Erlotinib dosage: (150 MG, QD), ORAL. Patient died on 05/19/2008.

Erlotinib Side Effects Report #5946023-2
Erlotinib side effect was reported by a Physician from ISRAEL on Oct 22, 2008. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cough, dyspnoea, nausea , pleural effusion, respiratory failure, sepsis . Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with NORMITEN, GASTRO, ASPIRIN. Patient was hospitalized. Patient died.


Erlotinib Side Effects Report #6051205-8
Erlotinib side effect was reported by a Physician from SPAIN on Jan 05, 2009. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchospasm, dyspnoea, herpes virus infection, hyperglycaemia, radiation pneumonitis, staphylococcal infection . Erlotinib dosage: (150 MG, QD), ORAL, (150 MG, QD), ORAL. During the same period patient was treated with PREDNISONA, SALBUTAMOL, OMEPRAZOLE, IPATROPIO BROMURO, FLUTICASONA, NOVOMIX, SERETIDE. Patient was hospitalized. Patient died on 07/22/2008.

Erlotinib Side Effects Report #4700720-5
Erlotinib side effect was reported by a Physician from on June 10, 2005. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abscess , anorexia, dehydration, dyspnoea, neoplasm progression, respiratory failure, syncope, tumour necrosis. Erlotinib dosage: 150 MG (QD),ORAL. During the same period patient was treated with PREDNISONE, THEOPHYLLINE, HYDROCHLOROTHIAZIDE, ACETYLCYSTEINE, SPIRULINA, FLUTICASONE PROPIONATE, FORMOTEROL. Patient was hospitalized. Patient died on 05/27/2005.

Erlotinib Side Effects Report #5285907-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 13, 2007. Male patient, 69 years of age, weighting 196.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, body temperature increased, cough, dyspnoea, haemoptysis, lung consolidation, lymphadenopathy, pain , pericardial effusion. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6125390-3
Erlotinib side effect was reported by a Physician from ITALY on Mar 02, 2009. Female patient, 69 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea. Erlotinib dosage: unknown. Patient was hospitalized. Patient died on 02/17/2009.

Erlotinib Side Effects Report #6024143-4
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on Dec 18, 2008. Male patient, 67 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: acute myocardial infarction, bronchial secretion retention, chills, condition aggravated, dyspnoea, metastases to lung, obstructive airways disorder, productive cough, pulmonary embolism . Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with HYDROCORTISONE, TRANEXAMIC ACID, CIPROFLOXACIN, BROMHEXINE, MEGESTROL ACETATE, OXYCODONE, MAGNESIUM OXIDE. Patient died.


Erlotinib Side Effects Report #5828472-6
Erlotinib side effect was reported by a Physician from JAPAN on July 14, 2008. Female patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bone marrow failure, dyspnoea, rash , thrombocytopenia. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with LOXONIN, SELBEX, GASTER D, LENDORM, MAGNESIUM OXIDE, AMLODIPINE BESYLATE, OXYCODONE, LIPITOR. Patient recovered.

Erlotinib Side Effects Report #5869626-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 19, 2008. Male patient, 66 years of age, weighting 181.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain , blood creatinine increased, blood sodium decreased, blood urea increased, dehydration, dyspnoea, fall , gastrooesophageal reflux disease, hyperkalaemia. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient died on 08/12/2008.

Erlotinib Side Effects Report #6140975-6
Erlotinib side effect was reported by a Physician from GREECE on Mar 17, 2009. Male patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, pulmonary embolism . Erlotinib dosage: (150 MG, QD FOR 12 DAYS, EVERY 21 DAYS), ORAL. During the same period patient was treated with TAXOTERE. Patient died on 02/07/2009.

Erlotinib Side Effects Report #5844660-7
Erlotinib side effect was reported by a Health Professional from BELGIUM on Aug 04, 2008. Female patient, 65 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cough, dyspnoea, febrile neutropenia. Erlotinib dosage: (150 MG, QD). During the same period patient was treated with PRAZEPAM, SPIRIVA, SYMBICORT, LANSOPRAZOLE, PRIMPERAN, BRUFEN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5875380-0
Erlotinib side effect was reported by a Physician from BELGIUM on Aug 21, 2008. Female patient, 65 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cough, dyspnoea, febrile neutropenia, hepatic function abnormal. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with CEFUROXIME AXETIL, PRAZEPAM, TIOTROPIUM, SYMBICORT, LANSOPRAZOLE, PRIMPERAN, IBUPROFEN. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #6058146-0
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Jan 13, 2009. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, fluid intake reduced, hypoxia, lethargy, malignant neoplasm progression, mobility decreased, pleural effusion, pneumonia . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with NYSTATIN, CITALOPRAM HYDROBROMIDE, LORAZEPAM, OXYCODONE. Patient was hospitalized. Patient died on 07/23/2008.

Erlotinib Side Effects Report #6140651-X
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on Mar 16, 2009. Male patient, 64 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, hypophagia, malignant neoplasm progression. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with METOCLOPRAMIDE, LOPERAMIDE, KYTRIL, STILNOX, ONDANSETRON, SMECTITE. Patient was hospitalized. Patient died on 05/22/2008.

Erlotinib Side Effects Report #4618260-0
Erlotinib side effect was reported by a Physician from on Mar 08, 2005. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cough, dyspnoea, jaundice . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with PANTOPRAZOLE, MORPHINE, FUROSEMIDE, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4631621-9
Erlotinib side effect was reported by a Physician from on Mar 23, 2005. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cough, dyspnoea, jaundice . Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with PANTOPRAZOLE, MORPHINE, FUROSEMIDE, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4901777-9
Erlotinib side effect was reported by a Pharmacist from UNITED STATES on Feb 01, 2006. Female patient, 62 years of age, weighting 74.50 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, dyspnoea, hyperhidrosis, pruritus, pyrexia, rash . Erlotinib dosage: 150MG DAILY PO. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #6058039-9
Erlotinib side effect was reported by a Physician from JAPAN on Jan 16, 2009. Male patient, 58 years of age, weighting 136.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, candidiasis, cough, crepitations, diarrhoea, disease progression, dyspnoea, hepatic cancer metastatic. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with FUDOSTEINE, NOVAMIN, FENTANYL, ITRACONAZOLE, CODEINE PHOSPHATE. Patient died on 12/24/2008.

Erlotinib Side Effects Report #5284467-5
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Mar 20, 2007. Female patient, 57 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood gases abnormal, chronic obstructive pulmonary disease, convulsion, dyspnoea, hyponatraemia, inappropriate antidiuretic hormone secretion, infection , lower respiratory tract infection, lung neoplasm malignant. Erlotinib dosage: unknown. During the same period patient was treated with SALBUTAMOL, SALMETEROL, ATROVENT, BENDROFLUAZIDE, PREDNISOLONE, MAXOLON, TEMAZEPAM. Patient was hospitalized. Patient died on 12/30/2006.

Erlotinib Side Effects Report #6132639-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 09, 2009. Female patient, 57 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchial neoplasm, cough, disease progression, dyspnoea, ejection fraction decreased, excessive granulation tissue, lobar pneumonia, myocardial infarction, obstructive airways disorder. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with DASATINIB, ALBUTEROL, SPIRIVA, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 02/27/2009.

Erlotinib Side Effects Report #5811060-5
Erlotinib side effect was reported by a Physician from SWITZERLAND on June 25, 2008. Female patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized and became disabled. Patient recovered.

Erlotinib Side Effects Report #5832819-4
Erlotinib side effect was reported by a Consumer or non-health professional from SWITZERLAND on July 17, 2008. Female patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea, respiratory failure. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized and became disabled. Patient recovered.


Erlotinib Side Effects Report #5856827-2
Erlotinib side effect was reported by a Physician from SWITZERLAND on Aug 08, 2008. Female patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea, malignant neoplasm progression, respiratory failure. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, CISPLATIN. Patient was hospitalized and became disabled. Patient died on 07/14/2008.

Erlotinib Side Effects Report #5712025-4
Erlotinib side effect was reported by a Physician from HONG KONG on Apr 03, 2008. Male patient, 53 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, lung consolidation, metastases to pleura, pleural effusion, sinus tachycardia. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient died on 03/20/2008.

Erlotinib Side Effects Report #5729636-2
Erlotinib side effect was reported by a Physician from HONG KONG on Apr 16, 2008. Male patient, 53 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, blood alkaline phosphatase increased, blood urea increased, dyspnoea, lower respiratory tract infection, lung consolidation, metastases to pleura, pleural effusion, sinus tachycardia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, LIDOCAINE, CHLORPHENIRAMINE MALEATE, BROMHEXINE HYDROCHLORIDE, TERBUTALINE SULPHATE, ALPRAZOLAM. Patient was hospitalized. Patient died on 03/20/2008.

Erlotinib Side Effects Report #4677230-7
Erlotinib side effect was reported by a Physician from on May 16, 2005. Male patient, 51 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, chest pain , dizziness , dyspnoea, fall . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with DEXAMETHASONE. Patient died on 05/05/2005.

Erlotinib Side Effects Report #6023121-9
Erlotinib side effect was reported by a Physician from CHINA on Dec 04, 2008. Male patient, 48 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea. Erlotinib dosage: unknown. Patient was hospitalized. Patient died on 01/14/2006.

Erlotinib Side Effects Report #6125547-1
Erlotinib side effect was reported by a Physician from CHINA on Mar 03, 2009. Male patient, 48 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea. Erlotinib dosage: unknown. Patient was hospitalized. Patient died on 01/14/2006.

Erlotinib Side Effects Report #5532822-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 30, 2007. Male patient, weighting 203.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, cough, dyspnoea, haemoptysis, hypoxia, lung infection, oxygen saturation decreased, pleural effusion, pyrexia. Erlotinib dosage: 150MG ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5549853-4
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 06, 2007. Male patient, weighting 203.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: computerised tomogram abnormal, cough, dyspnoea, haemoptysis, hypoxia, pleural effusion. Erlotinib dosage: 150MG ORALLY QD. During the same period patient was treated with DASATIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5652107-9
Erlotinib side effect was reported by a Physician from ITALY on Feb 19, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: agitation, chest pain , disease progression, dyspnoea, peripheral vascular disorder. Erlotinib dosage: 150 MG, QD, ORAL. Patient died.

Erlotinib Side Effects Report #5765626-1
Erlotinib side effect was reported by a Physician from UNITED STATES on June 06, 2008. Female patient, weighting 127.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease recurrence, dyspnoea, malignant pleural effusion, tachycardia. Erlotinib dosage: 150MG ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5829431-X
Erlotinib side effect was reported by a Physician from UNITED STATES on July 14, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, haematocrit decreased, haemoglobin decreased, pleuritic pain, productive cough. Erlotinib dosage: 150 MG, QD; ORAL. During the same period patient was treated with ALBUTEROL SULPHATE, ALPRAZOLAM, COMPAZINE, DUONEB, HYDROCODONE, PHENERGAN, SIMETHICONE, WELLBUTRIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5875348-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 22, 2008. Male patient, weighting 181.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain , dyspnoea, fall , hyperkalaemia, malignant neoplasm progression, musculoskeletal chest pain, oedema peripheral, pleural effusion. Erlotinib dosage: (150 MG,QD), ORAL. Patient died.

Erlotinib Side Effects Report #5918103-9
Erlotinib side effect was reported by a Physician from ITALY on Sept 24, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, dyspnoea, pulmonary embolism . Erlotinib dosage: 150 MG, QD, ORAL. Patient died on 09/02/2008.

Erlotinib Side Effects Report #6052696-9
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 05, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, hepatic neoplasm malignant, jaundice , oedema peripheral, productive cough. Erlotinib dosage: (150 MG) ,ORAL. Patient died.

Erlotinib Side Effects Report #6067764-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 20, 2009. Female patient, weighting 205.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood pressure decreased, breath sounds abnormal, coronary artery disease , depressed level of consciousness, dyspnoea, hypoxia, metastases to liver, oedema. Erlotinib dosage: (150 MG), ORAL. During the same period patient was treated with COMPLETE VITAMINS, ACTOS, LOW DOSE ASA, ZETIA, VITAMIN B12. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #6084839-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 04, 2009. Female patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, dyspnoea, hyperkalaemia, hypokalaemia, hypophosphataemia, neutrophilia, vomiting. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6099207-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 25, 2009. Female patient, weighting 108.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, influenza. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6120262-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 04, 2009. Female patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, dyspnoea, hyperkalaemia, hypokalaemia, hypophosphataemia, neutrophilia, renal failure. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient died on 02/17/2009.

Erlotinib Side Effects Report #4662640-4
Erlotinib side effect was reported by a Physician from on May 13, 2005. Male patient, 72 years of age, weighting 183.4 lb, was diagnosed with neoplasm malignant, respiratory disorder and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, condition aggravated, dyspnoea, dyspnoea at rest, dyspnoea exertional, hypoxia, infection , neoplasm malignant, pulmonary toxicity. Erlotinib dosage: 150MG QDAY ORAL. During the same period patient was treated with PROPRANOLOL, GUAIFENESIN, HYDROXYZINE, ALLOPURINOL, LEVAQUIN. Patient was hospitalized. Patient died on 05/08/2005.

Erlotinib Side Effects Report #5442832-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 28, 2007. Female patient, 79 years of age, weighting 101.0 lb, was diagnosed with metastatic neoplasm, neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, dysphagia, dyspnoea, vomiting. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5031282-3
Erlotinib side effect was reported by a Pharmacist from UNITED STATES on June 19, 2006. Male patient, 67 years of age, weighting 152.1 lb, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, effusion, lung infiltration, pneumonitis. Erlotinib dosage: 150 MG DAILY PO. Patient was hospitalized. Patient died on 06/16/2006.

Erlotinib Side Effects Report #5811361-0
Erlotinib side effect was reported by a Health Professional from JAPAN on June 26, 2008. Female patient, 66 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, rash , thrombocytopenia. Erlotinib dosage: unknown. During the same period patient was treated with LOXONIN, SELBEX, FAMOTIDINE, LENDORM, MAGNESIUM OXIDE, AMLODIPINE BESYLATE, OXYCODONE, LIPITOR. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6093028-X
Erlotinib side effect was reported by a Consumer or non-health professional from CHILE on Feb 10, 2009. Male patient was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, delirium, dyspnoea, oropharyngitis fungal, urinary tract infection . Erlotinib dosage: unknown. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6112567-6
Erlotinib side effect was reported by a Consumer or non-health professional from CHILE on Feb 23, 2009. Male patient was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, delirium, dyspnoea, fungal infection , fungal oesophagitis, mucosal inflammation, urinary tract infection . Erlotinib dosage: unknown. Patient was hospitalized and became disabled. Patient died.

Erlotinib Side Effects Report #5788681-1
Erlotinib side effect was reported by a Physician from JAPAN on June 09, 2008. Male patient, 69 years of age, was diagnosed with lung adenocarcinoma, pyrexia and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, disease progression, dyspnoea, pruritus, pyrexia, rash , rhinorrhoea. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with FINIBAX, ADALAT, MUCODYNE, HOKUNALIN, THEOLONG, PREDONINE. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5818453-0
Erlotinib side effect was reported by a Physician from JAPAN on July 03, 2008. Male patient, 69 years of age, was diagnosed with lung adenocarcinoma, pyrexia and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, disease progression, dyspnoea, pruritus, pyrexia, rash , rhinorrhoea. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with FINIBAX, ADALAT, MUCODYNE, HOKUNALIN, THEOLONG, PREDONINE. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5691936-2
Erlotinib side effect was reported by a Physician from JAPAN on Feb 15, 2008. Female patient, 57 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arterial disorder, dyspnoea, hypoxia, interstitial lung disease, nail disorder, no therapeutic response, palpatory finding abnormal, pleural effusion, pulmonary hypertension . Erlotinib dosage: (150 MG,QD),ORAL. Patient died on 01/24/2008.

Erlotinib Side Effects Report #5862217-9
Erlotinib side effect was reported by a Physician from JAPAN on Aug 12, 2008. Male patient, 53 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchostenosis, cardio-respiratory arrest, disease progression, dyspnoea, haemoptysis, hepatic function abnormal, rash , shock, white blood cell count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MEDICON, MUCOSOLVAN, MUCODYNE, ZOLPIDEM TARTRATE, LOXONIN, HUSTAGIN, APRICOT, CODEINE PHOSPHATE. Patient died on 07/26/2008.

Erlotinib Side Effects Report #5891591-2
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 04, 2008. Male patient, 53 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchostenosis, cardio-respiratory arrest, disease progression, dry skin, dyspnoea, haemoptysis, haemorrhage, hepatic function abnormal, rash . Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with MEDICON, MUCOSOLVAN, MUCODYNE, ZOLPIDEM TARTRATE, LOXONIN, HUSTAGIN, APRICOT, CODEINE PHOPHATE. Patient died on 07/26/2008.

Erlotinib Side Effects Report #5417341-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 14, 2007. Male patient, 48 years of age, weighting 231.0 lb, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: breath sounds abnormal, dehydration, dyspnoea, failure to thrive, large intestine perforation, malaise, oral intake reduced, wound dehiscence. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with SORAFENIB, DECADRON. Patient was hospitalized. Patient died on 05/08/2007.


Erlotinib Side Effects Report #5442833-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 17, 2007. Male patient, 48 years of age, weighting 231.0 lb, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, large intestine perforation, pneumatosis, thrombosis, wound dehiscence. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with SORAFENIB, DECADRON. Patient was hospitalized. Patient died on 05/08/2007.

Erlotinib Side Effects Report #5515867-3
Erlotinib side effect was reported by a Physician from DENMARK on Oct 25, 2007. Female patient, 55 years of age, was diagnosed with gastrointestinal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: catheter related complication, dyspnoea, haemoglobin decreased, infection , thrombocytopenia. Erlotinib dosage: (150 MG), ORAL. During the same period patient was treated with BEVACIZUMAB, TENORMIN, ACETAMINOPHEN, WHOLE BLOOD. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6016661-X
Erlotinib side effect was reported by a Physician from HONG KONG on Dec 05, 2008. Male patient, 65 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal distension, cardiac arrest , diarrhoea, dyspnoea, metabolic acidosis, vomiting. Erlotinib dosage: (25 MG) , ORAL. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient died on 12/02/2008.

Erlotinib Side Effects Report #6023214-6
Erlotinib side effect was reported by a Health Professional from HONG KONG on Dec 11, 2008. Male patient, 65 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal distension, cardiac arrest , diarrhoea, dyspnoea, haematemesis, metabolic acidosis. Erlotinib dosage: (25 MG, QD), ORAL. Patient was hospitalized. Patient died on 12/02/2008.

Erlotinib Side Effects Report #4987797-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 28, 2006. Female patient, 62 years of age, weighting 166.0 lb, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, infection . Erlotinib dosage: 150 MG PO. During the same period patient was treated with FERROUS SULPHATE, LOTREL, PERCOSET, CLARINEX, NEXIUM. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4997873-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 05, 2006. Female patient, 62 years of age, weighting 166.0 lb, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, infection . Erlotinib dosage: 150 MG PO. During the same period patient was treated with FERROUS SULPHATE, LOTREL, PERCOSET, CLARINEX, NEXIUM. Patient recovered.

Erlotinib Side Effects Report #4967272-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 15, 2006. Female patient, 58 years of age, weighting 121.9 lb, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest discomfort, disease progression, dyspnoea, haemoglobin decreased, pericardial effusion, pleural effusion, white blood cell count increased. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with EVEROLIMUS, HYDROCODONE BITARTRATE, TUSSIONEX, PHENYLTOLOXAMINE, LEVAQUIN, IRON, CALTRATE, VITAMIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5363515-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 18, 2007. Female patient, 40 years of age, weighting 220.0 lb, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activities of daily living impaired, atrial fibrillation , blood pressure decreased, dyspnoea, oedema, pleural effusion, respiratory disorder, sedation. Erlotinib dosage: unknown. Patient died on 06/06/2007.

Erlotinib Side Effects Report #6051310-6
Erlotinib side effect was reported by a Physician from JAPAN on Jan 05, 2009. Male patient, 77 years of age, weighting 90.39 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, constipation , diarrhoea, dyspnoea, exfoliative rash, fatigue, toothache, vomiting. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with SUNRYTHM, MUCOSTA, MUCOSOLVAN, SPIRIVA, TIZANIDINE, URSO, NEO MINOPHAGEN C, VERAPAMIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5844626-7
Erlotinib side effect was reported by a Physician from JAPAN on July 31, 2008. Male patient, 66 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ascites, bacterial infection , c-reactive protein increased, disease progression, dyspnoea, interstitial lung disease, liver disorder, malignant pleural effusion. Erlotinib dosage: (150 MG, QD) , ORAL. During the same period patient was treated with OXYCONTIN, NOVAMIN, OXINORM, ADONA, TRANSAMIN, LASIX, PURSENNID, CLARITHROMYCIN. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5015347-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 30, 2006. Female patient, 51 years of age, weighting 144.0 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, dizziness , dyspnoea, ear pain, ejection fraction decreased, hepatic ischaemia, hypotension. Erlotinib dosage: 100MG QD PO. During the same period patient was treated with AVASTIN, CISPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4697727-3
Erlotinib side effect was reported by a Pharmacist from on June 21, 2005. Male patient, 49 years of age, weighting 196.9 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, rash . Erlotinib dosage: unknown. Patient was hospitalized. Patient recovered.